Steven Neufeld, MD
Foot and Ankle Surgery · Falls Church, VANPI 1245310614
Payments from drug & device makers
What this record shows
The money is spread across several categories — royalties or licence payments (48.9%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 41 manufacturers reported payments, led by Stryker at 46.9% of the total. Among foot and ankle surgery clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 475 payments — averaging $1803.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$402K
- International Life Sciences$251K
- Linvatec Corporation$89K
- Vilex LLC$45K
- Merete Technologies, Inc$30K
- In2bones USA, LLC$11K
- plus $28K from 35 others
Across 7 payments — averaging $42,623 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi Pasteur Inc.$283K
- Kuros Biosciences USA, Inc$15K
Across 1 payment — averaging $2235.62 each. An ownership or investment interest held by the physician or an immediate family member.
- Oxford Performance Materials, Inc.$2K
What the payments were for
- Royalty or licence$419,07649%
- Consulting fees$369,09043%
- Speaking & faculty fees$5250%
- Grants$2,5000%
- Travel & lodging$48,4096%
- Food & beverage$9,8921%
- Education$6,2131%
- Other$8140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FLEXBAND$353,972
- PROstep$106,075
- IBS$99,017
- ACCOLADE$60,642
- PROPHECY$30,793
- ORTHOLOC 2 LAPIFUSE$25,185
- EASY CLIP$16,675
- EASYFUSE$16,675
- FUZE$14,103
- MagnetOs$7,025
- AUGMENT INJECTABLE$4,998
- T2$4,600
- INFINITY$3,925
- HINTERMANN$3,442
- PRIME SERIES$3,412
- DYNEX$3,079
- Avid$2,366
- Quantum Total Ankle$2,100
- VARIAX$1,544
- AXSOS$1,370
How this compares
$856,519 in reported general payments places this provider in the 95th percentile of 260 foot and ankle surgery providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 38 | $908 |
| Celecoxib | 33 | $721 |
| Meloxicam | 60 | $179 |
Paid to pharmacies, not to this prescriber.
Other foot and ankle surgery in Falls Church
- Daniel CutticaFalls Church$143K
- Thomas SandersFalls Church$41K
- Trevor KlinknerFalls Church$17K
- Mark JonesNorth Chesterfield$2.4M
- Oliver SchipperArlington$1.2M
- Charles ZelenRoanoke$363K
- Ryan VazalesGlen Allen$337K
- Jugal DhariaFairfax$309K
- William SimonVirginia Beach$292K
- William GrantVirginia Beach$271K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.